Moderna’s candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows
1 min read
Article by Karen Weintraub, USA TODAY.
A second COVID-19 candidate vaccine looks to be even more effective than the first: Both protect more than 90% of those who get the shots.
Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease. […]
